Likewise, no significant differences were observed between groups in the use of lipid-lowering or antihypertensive medications at baseline (Chi-square test: P = .112 and P = .059, respectively), despite a marked trend of use of such medication among the participants with obesity.
← all excerpts
Obesity as a Determinant of Periodontal Therapy Outcomes: Insights on Oxidative and Endoplasmic Reticulum Stress Pathways.
1
—
—